1 employees
NeuroTherapeutics Pharma develops therapeutics for patients suffering from central nervous system disorders.
2006
$43M
from 4 investors over 4 rounds
Neuro Therapeutics Inc. & University of British Columbia raised $43M on May 20, 2010
Investors: Thomas, McNerney & Partners, F-Prime Capital Partners, S.R. One Ltd and MPM Capital